Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19

van de Veerdonk, Frank L; Kouijzer, Ilse J E; de Nooijer, Aline H; van der Hoeven, Hans G; Maas, Coen; Netea, Mihai G; Brüggemann, Roger J M

doi:https://doi.org/10.1001/jamanetworkopen.2020.17708

Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19

DSpace/Manakin Repository

Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19

van de Veerdonk, Frank L; Kouijzer, Ilse J E; de Nooijer, Aline H; van der Hoeven, Hans G; Maas, Coen; Netea, Mihai G; Brüggemann, Roger J M

(2020) JAMA network open, volume 3, issue 8

(Letter)

Download/Full Text

Open Access version via Utrecht University Repository

Publisher version

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: Adult, Aged, Betacoronavirus, Bradykinin B2 Receptor Antagonists/therapeutic use, Bradykinin/analogs & derivatives, Coronavirus Infections/drug therapy, Female, Humans, Male, Middle Aged, Oxygen/blood, Pandemics, Pneumonia, Viral/drug therapy, Receptor, Bradykinin B2/metabolism, Journal Article

DOI: https://doi.org/10.1001/jamanetworkopen.2020.17708

ISSN: 2574-3805

Publisher: American Medical Association

(Peer reviewed)